Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents

Journal of Pediatrics

Volumn 162, Issue 5, 2013, Pages 937-941

  Roe, Andrea Hsu ^a   Prochaska, Erica ^a   Smith, Matthew ^a   Sammel, Mary ^a   Dokras, Anuja ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROLACTIN; THYROTROPIN;

ACNE; ADOLESCENT; ADOLESCENT DISEASE; ANDROGEN EXCESS PCOS SOCIETY CRITERIA; ARTICLE; BODY MASS; DISEASE CLASSIFICATION; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; OBESITY; OVARY POLYCYSTIC DISEASE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; THYROTROPIN BLOOD LEVEL; WEIGHT GAIN;

ADOLESCENT; ANDROGENS; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84876688134     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.11.019     Document Type: Article

References (23)

1. R.F. Vollman The menstrual cycle Major Probl Obstet Gynecol 7 1977 72 123
2. E. Carmina, S.E. Oberfield, and R.A. Lobo The diagnosis of polycystic ovary syndrome in adolescents Am J Obstet Gynecol 203 2010 201.e1 201.e5
3. R.L. Rosenfield Clinical review: identifying children at risk for polycystic ovary syndrome J Clin Endocrinol Metab 92 2007 787 796
4. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 2009 456 488
5. M.B. Porter, R. Brown, S.R. Goldstein, D. Paushter, E. Puscheck, and C. Coutifaris AIUM practice guideline for ultrasonography in reproductive medicine J Ultrasound Med 28 2009 128 137
6. W.D. Johnson, J.J. Kroon, F.L. Greenway, C. Bouchard, D. Ryan, and P.T. Katzmarzyk Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006 Arch Pediatr Adolesc Med 163 2009 371 377
7. M.H. van Hooff, F.J. Voorhorst, M.B. Kaptein, R.A. Hirasing, C. Koppenaal, and J. Schoemaker Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years Hum Reprod 19 2004 383 392
8. M.H. van Hooff, F.J. Voorhorst, M.B. Kaptein, R.A. Hirasing, C. Koppenaal, and J. Schoemaker Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin Fertil Steril 74 2000 49 58
9. R. Hart, D.A. Doherty, T. Mori, R.C. Huang, R.J. Norman, and S. Franks Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome Fertil Steril 95 2011 2347 2353
10. I. Souter, L.A. Sanchez, M. Perez, A.A. Bartolucci, and R. Azziz The prevalence of androgen excess among patients with minimal unwanted hair growth Am J Obstet Gynecol 191 2004 1914 1920
11. S. Ozdemir, M. Ozdemir, H. Görkemli, A. Kiyici, and S. Bodur Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism Acta Obstet Gynecol Scand 89 2010 199 204
12. A.D. Coviello, R.S. Legro, and A. Dunaif Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance J Clin Endocrinol Metab 91 2006 492 497
13. N.I. Leibel, E.E. Baumann, M. Kocherginsky, and R.L. Rosenfield Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome J Clin Endocrinol Metab 91 2006 1275 1283
14. S.M. Bhattacharya, and A. Jha Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria' J Obstet Gynaecol Res 37 2011 1303 1307
15. J. Huang, R. Ni, X. Chen, L. Huang, Y. Mo, and D. Yang Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China Reprod Biol Endocrinol 8 2010 142
16. B. Rossi, S. Sukalich, J. Droz, A. Griffin, S. Cook, and A. Blumkin Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome J Clin Endocrinol Metab 93 2008 4780 4786
17. A. Fulghesu, R. Magnini, E. Portoghese, S. Angioni, L. Minerba, and G.B. Melis Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome Adolesc Health 46 2010 474 481
18. F. Fruzzetti, D. Perini, V. Lazzarini, D. Parrini, and A.R. Genazzani Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels Fertil Steril 92 2009 626 634
19. G.S. Berenson, S.R. Srinivasan, W. Bao, W.P. Newman III, R.E. Tracy, and W.A. Wattigney Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study N Engl J Med 338 1998 1650 1656
20. W. Bao, S.R. Srinivasan, W.A. Wattigney, and G.S. Berenson Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: the Bogalusa Heart Study Arch Intern Med 154 1994 1842 1847
21. S.R. Daniels, D.K. Amett, R.H. Eckel, S.S. Gidding, L.L. Hayman, and S. Kumanyika Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment Circulation 111 2005 1999 2012
22. N. Lass, M. Kleber, K. Winkel, R. Wunsch, and T. Reinehr Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls J Clin Endocrinol Metab 96 2011 3533 3540
23. D.H. Geller, D. Pacaud, C.M. Gordon, M. Misra Drug and Therapeutics Committee of the Pediatric Endocrine Society State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS) Int J Pediatr Endocrinol 2011 2011 9